Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George Liapakis

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
Plos One|July 19, 2011
A novel role of peripheral corticotropin-releasing hormone (CRH) on dermal fibroblastsOlga Rassouli, George Liapakis, Iakovos Lazaridis, et al.
The Journal of Biological Chemistry|January 10, 2019
Nonconventional glucagon and GLP-1 receptor agonist and antagonist interplay at the GLP-1 receptor revealed in high-throughput FRET assays for cAMPOleg G Chepurny, Minos-Timotheos Matsoukas, George Liapakis, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 26, 2010
Evaluation of a stable gonadotropin-releasing hormone analog in mice for the treatment of endocrine disorders and prostate cancerTheodora Katsila, Evangelos Balafas, George Liapakis, et al.
European Journal of Medicinal Chemistry|August 15, 2012
The discovery of new potent non-peptide Angiotensin II AT1 receptor blockers: a concise synthesis, molecular docking studies and biological evaluation of N-substituted 5-butylimidazole derivativesGeorge Agelis, Amalia Resvani, Serdar Durdagi, et al.
The Journal of Biological Chemistry|May 20, 2014
Structural-functional analysis of the third transmembrane domain of the corticotropin-releasing factor type 1 receptor: role in activation and allosteric antagonismKaterina Spyridaki, Minos-Timotheos Matsoukas, Arnau Cordomi, et al.
General and Comparative Endocrinology|May 10, 2025
GLP-1 receptor agonist properties of a chimeric peptide derived by hybridization of Latrodectus αLatrotoxin and Heloderma Exendin-4Oleg G Chepurny, Amber N Liles, Nancy Cham, et al.
Molecules (Basel, Switzerland)|September 14, 2024
Cytotoxic Activity of Novel GnRH Analogs Conjugated with Mitoxantrone in Ovarian Cancer CellsChristos Markatos, Georgia Biniari, Oleg G Chepurny, et al.
International Journal of Molecular Sciences|October 28, 2023
Rational Design, Synthesis and Binding Affinity Studies of Anthraquinone Derivatives Conjugated to Gonadotropin-Releasing Hormone (GnRH) Analogues towards Selective Immunosuppression of Hormone-Dependent CancerGeorgia Biniari, Christos Markatos, Agathi Nteli, et al.
Current Pharmaceutical Biotechnology|November 7, 2014
G protein-coupled receptor signaling to Kir channels in Xenopus oocytesCandice Hatcher-Solis, Miguel Fribourg, Katerina Spyridaki, et al.
Bioconjugate Chemistry|March 26, 2014
GnRH-Gemcitabine conjugates for the treatment of androgen-independent prostate cancer: pharmacokinetic enhancements combined with targeted drug deliveryTheodoros Karampelas, Orestis Argyros, Nisar Sayyad, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Plos One|July 19, 2011
A novel role of peripheral corticotropin-releasing hormone (CRH) on dermal fibroblastsOlga Rassouli, George Liapakis, Iakovos Lazaridis, et al.
The Journal of Biological Chemistry|January 10, 2019
Nonconventional glucagon and GLP-1 receptor agonist and antagonist interplay at the GLP-1 receptor revealed in high-throughput FRET assays for cAMPOleg G Chepurny, Minos-Timotheos Matsoukas, George Liapakis, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 26, 2010
Evaluation of a stable gonadotropin-releasing hormone analog in mice for the treatment of endocrine disorders and prostate cancerTheodora Katsila, Evangelos Balafas, George Liapakis, et al.
European Journal of Medicinal Chemistry|August 15, 2012
The discovery of new potent non-peptide Angiotensin II AT1 receptor blockers: a concise synthesis, molecular docking studies and biological evaluation of N-substituted 5-butylimidazole derivativesGeorge Agelis, Amalia Resvani, Serdar Durdagi, et al.
The Journal of Biological Chemistry|May 20, 2014
Structural-functional analysis of the third transmembrane domain of the corticotropin-releasing factor type 1 receptor: role in activation and allosteric antagonismKaterina Spyridaki, Minos-Timotheos Matsoukas, Arnau Cordomi, et al.
General and Comparative Endocrinology|May 10, 2025
GLP-1 receptor agonist properties of a chimeric peptide derived by hybridization of Latrodectus αLatrotoxin and Heloderma Exendin-4Oleg G Chepurny, Amber N Liles, Nancy Cham, et al.
Molecules (Basel, Switzerland)|September 14, 2024
Cytotoxic Activity of Novel GnRH Analogs Conjugated with Mitoxantrone in Ovarian Cancer CellsChristos Markatos, Georgia Biniari, Oleg G Chepurny, et al.
International Journal of Molecular Sciences|October 28, 2023
Rational Design, Synthesis and Binding Affinity Studies of Anthraquinone Derivatives Conjugated to Gonadotropin-Releasing Hormone (GnRH) Analogues towards Selective Immunosuppression of Hormone-Dependent CancerGeorgia Biniari, Christos Markatos, Agathi Nteli, et al.
Current Pharmaceutical Biotechnology|November 7, 2014
G protein-coupled receptor signaling to Kir channels in Xenopus oocytesCandice Hatcher-Solis, Miguel Fribourg, Katerina Spyridaki, et al.
Bioconjugate Chemistry|March 26, 2014
GnRH-Gemcitabine conjugates for the treatment of androgen-independent prostate cancer: pharmacokinetic enhancements combined with targeted drug deliveryTheodoros Karampelas, Orestis Argyros, Nisar Sayyad, et al.
Pageof 5